How much funding has E-Scape Bio raised?

E-Scape Bio has raised $136.0M in total funding, most recently a Series B round.

Who are E-Scape Bio's investors?

E-Scape Bio's investors include Wellington Management, Sutter Hill, Avidity Partners, CAM Capital, New Leaf Ventures, Rock Springs Capital.

When was E-Scape Bio founded?

E-Scape Bio was founded in 2015.

Where is E-Scape Bio headquartered?

E-Scape Bio is headquartered in South San Francisco, California, United States.

What industry is E-Scape Bio in?

E-Scape Bio operates in Biotech, Healthcare.

How many employees does E-Scape Bio have?

E-Scape Bio has 11-50 employees.

E-Scape Bio

Welcome to e-Scape Bio !

South San Francisco, United States · Founded 2015 · $136.0M raised

Biotech

Healthcare

Headquarters: South San Francisco, California
Employees: 11–50
Founded: 2015
Business Model: B2B

Website: e-scapebio.com
Total Funding: $136.0M
Last Round: $73.0M Series BSep 2020
Rounds: 2

About

E-Scape Bio is a clinical-stage biopharma developing precision small-molecule therapies for genetically defined neurodegenerative diseases (Alzheimer's, Parkinson's). Targets apoE4 and similar genetic pathways.

Summary

E-Scape Bio is a Biotech company based in South San Francisco, United States, founded in 2015. It has raised $136.0M in total across 2 rounds, most recently a $73.0M Series B round in Sep 2020. Investors include Wellington Management, Sutter Hill and Avidity Partners.